Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Answer to Photoquiz An impressive chest X-ray….
Heidt J, van Keulen EM, Willemsen AECAB, van Haarst JMW. Heidt J, et al. Among authors: willemsen aecab. Neth J Med. 2020 Dec;78(6):393-394. Neth J Med. 2020. PMID: 33380541 Free article. No abstract available.
An impressive chest X-ray….
Heidt J, van Keulen EM, Willemsen AECAB, van Haarst JMW. Heidt J, et al. Among authors: willemsen aecab. Neth J Med. 2020 Dec;78(6):392. Neth J Med. 2020. PMID: 33380540 Free article. No abstract available.
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer.
Boerrigter E, Overbeek JK, Benoist GE, Somford DM, Hamberg P, Tol J, Scholtes B, Willemsen AECAB, Buffart LM, Kessels RPC, Mehra N, van Oort IM, van Erp NP. Boerrigter E, et al. Among authors: willemsen aecab. Eur Urol Oncol. 2024 Dec;7(6):1376-1383. doi: 10.1016/j.euo.2024.02.009. Epub 2024 Mar 13. Eur Urol Oncol. 2024. PMID: 38485614 Free article. Clinical Trial.
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane.
Willemsen AECAB, He X, van Cranenbroek B, de Jong PC, de Boer M, Joosten I, Koenen HJPM, van Herpen CML, Gerritsen WR. Willemsen AECAB, et al. Int Immunopharmacol. 2021 Apr;93:107404. doi: 10.1016/j.intimp.2021.107404. Epub 2021 Jan 30. Int Immunopharmacol. 2021. PMID: 33524804 Free article. Clinical Trial.
STAT3 as a predictive biomarker in head and neck cancer: A validation study.
van Ruitenbeek NJ, van der Woude LL, van Krieken JH, van Engen-van Grunsven ACH, Willemsen AECAB, van Herpen CML. van Ruitenbeek NJ, et al. Among authors: willemsen aecab. Pathol Res Pract. 2020 Nov;216(11):153172. doi: 10.1016/j.prp.2020.153172. Epub 2020 Aug 17. Pathol Res Pract. 2020. PMID: 32858373 Free article.
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane.
Willemsen AECAB, de Geus-Oei LF, de Boer M, Tol J, Kamm Y, de Jong PC, Jonker MA, Vos AH, Grootjans W, de Groot JWB, Mulder SF, Aarntzen EHJG, Gerritsen WR, van Herpen CML, van Erp NP. Willemsen AECAB, et al. Target Oncol. 2018 Oct;13(5):641-648. doi: 10.1007/s11523-018-0596-8. Target Oncol. 2018. PMID: 30259313
20 results